
Sign up to save your podcasts
Or
Drs. Karl and Spencer discuss the topline results from Surmount 5 which put Zepbound (tirzepatide) against Wegovy (semaglutide) for weight loss. They also discuss some news around compounded GLP-1s.
Learn:
Weight loss and glycemic differences between tirzepatide and semaglutide
What the FDA is thinking for compounded GLP-1s
If you're not on Dr. Spencer's virtual clinic waitlist, click here
4.7
356356 ratings
Drs. Karl and Spencer discuss the topline results from Surmount 5 which put Zepbound (tirzepatide) against Wegovy (semaglutide) for weight loss. They also discuss some news around compounded GLP-1s.
Learn:
Weight loss and glycemic differences between tirzepatide and semaglutide
What the FDA is thinking for compounded GLP-1s
If you're not on Dr. Spencer's virtual clinic waitlist, click here
495 Listeners
3,552 Listeners
1,172 Listeners
2,096 Listeners
333 Listeners
36 Listeners
320 Listeners
497 Listeners
1,546 Listeners
1,102 Listeners
56 Listeners
160 Listeners
143 Listeners
98 Listeners
214 Listeners